Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Institutional Ownership: 1.12% (As of Sep. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600420 Shanghai Shyndec Pharmaceutical Co Ltd SHSE:600420
56 GF Score
Price ¥8.29
GF Value ¥10.79
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Shyndec Pharmaceutical Co Institutional Ownership?

Shanghai Shyndec Pharmaceutical Co SHSE:600420 -2.01% 56 Institutional Ownership is 1.12% as of Sep. 11, 2026. GuruFocus rates SHSE:600420 with a GF Score™ of 56/100 and a GF Value™ of ¥10.79 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Shanghai Shyndec Pharmaceutical Co's institutional ownership is 1.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Shanghai Shyndec Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Shanghai Shyndec Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Shanghai Shyndec Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Shanghai Shyndec Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Shyndec Pharmaceutical Co Institutional Ownership Chart

Shanghai Shyndec Pharmaceutical Co Historical Data

The historical data trend for Shanghai Shyndec Pharmaceutical Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 3.09 3.09 2.40 2.37 2.38 2.39 2.38 1.09 1.12 1.12
SHSE:600420
56GF Score
Shanghai Shyndec Pharmaceutical Co Ltd SHSE:600420
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Shyndec Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 1.12% mean?
Shanghai Shyndec Pharmaceutical Co (SHSE:600420) has a Institutional Ownership of 1.12% as of Sep. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Shanghai Shyndec Pharmaceutical Co and its competitors.
Is Shanghai Shyndec Pharmaceutical Co's Institutional Ownership too high?
Shanghai Shyndec Pharmaceutical Co's current Institutional Ownership is 1.12%. Overall, Shanghai Shyndec Pharmaceutical Co has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shyndec Pharmaceutical Co's Institutional Ownership compare to ZTS?
Shanghai Shyndec Pharmaceutical Co's Institutional Ownership of 1.12% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Shanghai Shyndec Pharmaceutical Co and its competitors. Shanghai Shyndec Pharmaceutical Co's current Institutional Ownership is 1.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shyndec Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shyndec Pharmaceutical Co (SHSE:600420) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.79, compared to a current price of ¥8.29 — trading 23.2% below its estimated fair value. The current Institutional Ownership is 1.12%. Shanghai Shyndec Pharmaceutical Co's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Shanghai Shyndec Pharmaceutical Co (SHSE:600420), the current Institutional Ownership is 1.12% as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Shyndec Pharmaceutical Co (SHSE:600420) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Shyndec Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.29 is trading 23.2% below its estimated GF Value™ of ¥10.79. GuruFocus considers Shanghai Shyndec Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600420:

  • Institutional Ownership: 1.12%
  • GF Value™: ¥10.79 vs. price of ¥8.29 (23.2% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the SHSE:600420 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Shyndec Pharmaceutical Co Business Description

Address No.1320 Beijinxi Road, Shanghai, CHN, 200040
Shanghai Shyndec Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical preparations, biological pharmaceuticals, chemical raw materials, and Chinese medicine formulations in China and internationally. It provides biological and chemical raw material medicines, microbial fermentation products and tablets, capsules, granules, injections, suspensions, and suppositories, as well as ointments, including product formulations.
56GF Score

Get the complete analysis for SHSE:600420

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.29
Price
¥10.79
GF Value